• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Profound Medical Corp. - common stock (NQ:PROF)

    6.190 -0.110 (-1.75%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 235,930
    Open 6.190
    Bid (Size) 6.140 (200)
    Ask (Size) 6.220 (200)
    Prev. Close 6.300
    Today's Range 5.940 - 6.440
    52wk Range 3.760 - 8.950
    Shares Outstanding 20,208,948
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
    From Profound Medical Corp.
    Via GlobeNewswire

    Performance

    YTD
    -19.2%
    -19.2%
    1 Month
    -13.4%
    -13.4%
    3 Month
    -16.0%
    -16.0%
    6 Month
    +20.9%
    +20.9%
    1 Year
    -4.8%
    -4.8%

    More News

    Read More
    News headline image
    Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 13, 2025 ↗
    Via Benzinga
    Here are the top movers in Friday's session. ↗
    Via Chartmill
    News headline image
    Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Announces Upcoming Investor Events
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
    From Profound Medical Corp.
    Via GlobeNewswire
    InvestorNewsBreaks – Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) Closes $36 Million Registered Direct Offering
    Via Investor Brand Network
    News headline image
    Profound Medical Corp. Announces Closing of Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Corp. Announces Upsize of Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Reports Strong Third Quarter 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
    From Profound Medical Corp.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Profound Medical Corp. - common stock publicly traded?
    Yes, Profound Medical Corp. - common stock is publicly traded.
    What exchange does Profound Medical Corp. - common stock trade on?
    Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Profound Medical Corp. - common stock?
    The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
    What is the current price of Profound Medical Corp. - common stock?
    The current price of Profound Medical Corp. - common stock is 6.190
    When was Profound Medical Corp. - common stock last traded?
    The last trade of Profound Medical Corp. - common stock was at 03/27/26 04:00 PM ET
    What is the market capitalization of Profound Medical Corp. - common stock?
    The market capitalization of Profound Medical Corp. - common stock is 125.09M
    How many shares of Profound Medical Corp. - common stock are outstanding?
    Profound Medical Corp. - common stock has 125M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.